T1	Participants 549 670	471 patients who were part of a prospective, randomized, controlled trial from 2003 to 2007 were retrospectively reviewed
T2	Participants 887 965	147 patients (31.2%) required a ventriculoperitoneal shunt (VPS) in our series
T3	Participants 1627 1674	Patients who did not receive a VPS at discharge
T4	Participants 1906 1967	among patients treated by endovascular or microsurgical means
T5	Participants 1969 2042	Patients in whom shunt-dependent hydrocephalus does not develop after SAH
